CFH Y402H polymorphism and response to intravitreal ranibizumab in Brazilian patients with neovascular age-related macular degeneration. [electronic resource]
Producer: 20161213Description: 386-92 p. digitalISSN:- 1809-4546
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- administration & dosage
- Brazil
- Complement Factor H -- genetics
- Female
- Humans
- Intravitreal Injections
- Male
- Middle Aged
- Polymorphism, Single Nucleotide
- Ranibizumab -- administration & dosage
- Retrospective Studies
- Treatment Outcome
- Wet Macular Degeneration -- drug therapy
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.